Drreddys Laboratories reported INR11.69B in Loan Capital for its fiscal quarter ending in September of 2026.





Loan Capital Change Date
ANI Pharmaceuticals USD 274.31M 5.84M Sep/2026
Aurora Cannabis CAD 16.81M 1.32M Jun/2026
Bayer EUR 37.7B 6.54B Sep/2026
Canopy Growth CAD 211.38M 5.74M Jun/2026
Cipla INR 4.69B 874.1M Sep/2026
Drreddys Laboratories INR 11.69B 510M Sep/2026
GlaxoSmithKline GBP 21.7B 7.75B Sep/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Novartis USD 38.38B 893M Sep/2026
Phibro Animal Health USD 585.85M 11.83M Sep/2026
Prestige Brands USD 2.08B 54.81M Sep/2026
Richter Gedeon HUF 79.37B 64.3B Jun/2026
Sun Pharmaceuticals INR 4.17B 237.8M Sep/2026
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 12.68B 588M Sep/2026